PDS Biotechnology (Germany) Analysis

PDS Stock Analysis Notes

About 14.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.91. PDS Biotechnology Corp had not issued any dividends in recent years. The entity had 1:20 split on the 18th of March 2019. PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. PDS Biotechnology Corporation was founded in 2005 and is based in Florham Park, New Jersey. PDS BIOTECHNOLOGY operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 15 people. To learn more about PDS Biotechnology Corp call Frank BeduAddo at 800 208 3343 or check out https://www.pdsbiotech.com.

PDS Biotechnology Corp Investment Alerts

PDS Biotechnology Thematic Classifications

PDS Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 206 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate PDS Biotechnology's market, we take the total number of its shares issued and multiply it by PDS Biotechnology's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 6th of January, PDS Biotechnology holds the Risk Adjusted Performance of (0.07), market risk adjusted performance of (14.65), and Coefficient Of Variation of (976.18). PDS Biotechnology Corp technical analysis gives you tools to exploit past prices in attempt to determine a pattern that determines the direction of the company's future prices. Please check PDS Biotechnology Corp mean deviation, standard deviation, information ratio, as well as the relationship between the coefficient of variation and variance to decide if PDS Biotechnology Corp is priced more or less accurately, providing market reflects its current price of 1.67 per share.

PDS Biotechnology Corp Price Movement Analysis

PDS Biotechnology Outstanding Bonds

PDS Biotechnology Predictive Daily Indicators

PDS Biotechnology Forecast Models

PDS Biotechnology's time-series forecasting models are one of many PDS Biotechnology's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary PDS Biotechnology's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how PDS Biotechnology prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling PDS shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as PDS Biotechnology. By using and applying PDS Stock analysis, traders can create a robust methodology for identifying PDS entry and exit points for their positions.

When running PDS Biotechnology's price analysis, check to measure PDS Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PDS Biotechnology is operating at the current time. Most of PDS Biotechnology's value examination focuses on studying past and present price action to predict the probability of PDS Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PDS Biotechnology's price. Additionally, you may evaluate how the addition of PDS Biotechnology to your portfolios can decrease your overall portfolio volatility.